Speech apraxia
Gene: PPP2R5D
Individual with CAS reported with de novo missense variant, c.751 G > T; p.(Asp251Tyr) (Van Niel et al., 2026; PMID: 41530369). Validated diagnostic finding from VCGS clinical NATA pipeline
Mitchel et al. (2025; PMID: 39931922) report one individual with PPP2R5D variant with CAS (Supp Table 6).
Almost all individuals with a PPP2R5D variant have speech impairment, hallmark of disorder (PMID: 32074998)
Sources: Expert List, LiteratureCreated: 29 Apr 2026, 1:49 p.m. | Last Modified: 29 Apr 2026, 3:25 p.m.
Panel Version: 1.31
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Intellectual developmental disorder 35 (MIM#616355)
Publications
Gene: ppp2r5d has been classified as Green List (High Evidence).
Gene: ppp2r5d has been classified as Green List (High Evidence).
gene: PPP2R5D was added gene: PPP2R5D was added to Speech apraxia. Sources: Expert List,Literature Mode of inheritance for gene: PPP2R5D was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: PPP2R5D were set to 41530369; 39931922; 32074998 Phenotypes for gene: PPP2R5D were set to Intellectual developmental disorder 35 (MIM#616355) Review for gene: PPP2R5D was set to GREEN